XML 63 R27.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Cash flows from operating activities:    
Net income $ 2,305 $ 2,228
Adjustments to reconcile net income to net cash flows from operating activities:    
Gains (losses) on marketable securities, net (336) 8
Depreciation and amortization 2,147 1,943
Allowance for equity funds (75) (59)
Equity income, net of distributions 17 (14)
Changes in regulatory assets and liabilities 263 17
Deferred income taxes and amortization of investment tax credits (116) 573
Other, net 40 21
Changes in other operating assets and liabilities, net of effects from acquisitions:    
Trade receivables and other assets (192) (82)
Derivative collateral, net 9 (16)
Pension and other postretirement benefit plans (61) (29)
Accrued property, income and other taxes, net 190 390
Accounts payable and other liabilities 168 170
Net cash flows from operating activities 5,031 5,134
Cash flows from investing activities:    
Capital expenditures (4,203) (3,179)
Acquisitions, net of cash acquired   (1,102)
Purchases of marketable securities 287 167
Proceeds from sales of marketable securities 266 186
Equity method investments (236) (80)
Other, net 48 (12)
Net cash flows from investing activities (4,517) (4,354)
Cash flows from financing activities:    
Proceeds from BHE senior debt 3,166 0
Repayments of BHE senior debt and junior subordinated debentures (650) (1,344)
Common stock purchases (107) (19)
Proceeds from subsidiary debt 2,353 1,562
Repayments of subsidiary debt (2,297) (834)
Net (repayments of) proceeds from short-term debt (2,694) 365
Purchase of redeemable noncontrolling interest (131) 0
Other, net (32) (60)
Net cash flows from financing activities (392) (330)
Effect of exchange rate changes (3) 6
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 119 456
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $ 1,402 $ 1,459